USADA suspends Lemos for two years
Amanda Lemos, of Belem, Brazil, has tested positive for a prohibited substance and accepted a two-year sanction for her anti-doping policy violation.
USADA has announced that UFC women’s bantamweight Amanda Lemos has accepted a two-year suspension, after failing an anti-doping test.
Via USADA.org.
Amanda Lemos, of Belém, Brazil, has tested positive for a prohibited substance and accepted a two-year sanction for her anti-doping policy violation.
Lemos, 30, tested positive for stanozolol and its metabolite 16β-hydroxystanozolol following an out-of-competition urine test conducted on November 8, 2017. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Lemos’ two-year period of ineligibility, the standard sanction for a first offense involving a non-Specified Substance, began on November 8, 2017, the date her positive sample was collected.
Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.
Lemos began fighting professionally in 2014, and earned a 6-0-1 record record before being signed with the UFC. In her league debut she was stopped in Round 2 by Leslie Smith at UFC Fight Night 113 on July 16, 2017.
Stanozolol, known by the brand name Winstrol, is a notorious PED. Past MMA fighters who have tested positive for the banned substance include Phil Baroni, Rafael ‘Feijao’ Cavalcante, Chris Leben, Kimo Leopoldo, Cris ‘Cyborg’ Santos, Ken Shamrock and Tim Sylvia. More recently, USADA has caught Carlos Felipe, Viscardi Andrade, Guido Cannetti, and now Lemos.
